MeiraGTx Holdings (MGTX) Capital Leases (2017 - 2025)

MeiraGTx Holdings (MGTX) reported Capital Leases of $109000.0 for Q4 2025, down 99.36% quarter-over-quarter from $17.1 million in Q3 2020.

MeiraGTx Holdings (MGTX) Capital Leases (2017 - 2025) Analysis & Trends

MeiraGTx Holdings has reported Capital Leases for 5 years, with the latest figure at $109000.0 in Q4 2025.

For the quarter ending Q4 2025, Capital Leases changed N/A year-over-year to $109000.0; the trailing twelve-month figure through Dec 2025 stood at $109000.0 (changed N/A YoY), and the FY2025 full-year result was $109000.0, changed N/A from the prior year.
Capital Leases for Q4 2025 stood at $109000.0, down from $17.1 million in the prior quarter.
The five-year high for Capital Leases was $109000.0 in Q4 2025, with the low at $109000.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn
9	Abivax	91.96 Bn	91.96 Bn	-
10	MeiraGTx Holdings	910.47 Mn	844.54 Mn	74.89 Mn

Download Data